We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

17 hedge funds and large institutions have $2.08M invested in Tenax Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

137% more capital invested

Capital invested by funds: $876K → $2.08M (+$1.2M)

89% more funds holding

Funds holding: 9 → 17 (+8)

0% more ownership

Funds ownership: 0.01% → 0.02% (+0%)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$424K
2
Two Sigma Investments
Two Sigma Investments
New York
+$143K
3
Renaissance Technologies
Renaissance Technologies
New York
+$122K
4
WS
Wedbush Securities
California
+$48.5K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$38.2K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$104K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$20K
3
SM
Sabby Management
Florida
-$19K
4
UBS Group
UBS Group
Switzerland
-$1.47K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$646K +$122K +83 +23%
BlackRock
2
BlackRock
New York
$543K – – –
TCM
3
Tang Capital Management
California
$416K +$424K +288 New
Two Sigma Investments
4
Two Sigma Investments
New York
$140K +$143K +97 New
FWP
5
FAS Wealth Partners
Kansas
$53K – – –
WS
6
Wedbush Securities
California
$47K +$48.5K +33 New
VF
7
Virtu Financial
New York
$41K +$41.2K +28 New
Two Sigma Advisers
8
Two Sigma Advisers
New York
$37K +$38.2K +26 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$29K – – –
Ameriprise
10
Ameriprise
Minnesota
$27K +$27.9K +19 New
Goldman Sachs
11
Goldman Sachs
New York
$20K +$20.6K +14 New
Citadel Advisors
12
Citadel Advisors
Florida
$18K +$19.1K +13 New
HF
13
HRT Financial
New York
$18K +$19.1K +13 New
HWA
14
HCR Wealth Advisors
California
$14K +$14.7K +10 New
Vanguard Group
15
Vanguard Group
Pennsylvania
$11K – – –
Northern Trust
16
Northern Trust
Illinois
$11K +$10.3K +7 New
William Blair & Company
17
William Blair & Company
Illinois
$9K +$8.82K +6 New
AC
18
Armistice Capital
New York
– -$104K -113 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$20K -22 Closed
SM
20
Sabby Management
Florida
– -$19K -21 Closed
UBS Group
21
UBS Group
Switzerland
– -$1.47K -1 Closed

TENX Hedge Fund Activity: Q2 2020 in Review

17 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2020, worth a combined $2.08M — up 137% from $876K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TENX positions and 4 closed out — a net gain of 8 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $424K. The largest seller was Armistice Capital, exiting entirely with an estimated $104K sold.

  • 17 institutional investors held Tenax Therapeutics (TENX) as of Q2 2020, up from 9 in Q1 2020.
  • Funds reported $2.08M of Tenax Therapeutics stock for Q2 2020, up 137% quarter-over-quarter.
  • 12 funds opened new Tenax Therapeutics positions in Q2 2020 and 4 closed out, a net change of +8 holders.
  • The largest Tenax Therapeutics buyer in Q2 2020 was Tang Capital Management, an estimated $424K added.
  • The largest Tenax Therapeutics seller in Q2 2020 was Armistice Capital, an estimated $104K sold.

Based on aggregated 13F filings for Q2 2020.